An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

ACUVAIL®

Drug Information Related Patent

Hold Company

ABBVIE

Learn More

Dosage and Administration

SOLUTION/DROPS;OPHTHALMIC

Specification

0.45%

Indication

ACUVAIL® is indicated for the treatment of pain and inflammation after cataract surgery.

Use

Instructions for Use

API

KETOROLAC TROMETHAMINE

API Structure

We Supply

KETOROLAC TROMETHAMINE

Note:

USP
Facility GMP
Product GMP
USMF/CEP

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
7842714	2029/8/15
8512717	2028/3/7
8992952	2024/8/5
9192571	2028/3/7

API Patent

Patent No	Expiration Date
7842714	2029/8/15

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION